← Back to Search

18F-DCFPyL Injection for Cancer

Phase 1
Waitlist Available
Led By Steven Rowe, M.D., Ph.D
Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Summary

This trial will use a new imaging agent, 18F-DCFPyL, to detect none prostate cancer solid malignancies and schwannoma tumors using PET/CT.

Eligible Conditions
  • Cancer
  • Schwannoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine feasibility of using 18F-DCFPyL to detect cancer

Side effects data

From 2018 Phase 2 & 3 trial • 385 Patients • NCT02981368
1%
pyelonephritis, acute
1%
spinal cord compression
1%
atrial fibrillation
1%
hyperkalaemia
1%
coronary artery disease
1%
Lower gastrointestinal haemmorhage
1%
dysgeusia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Recurrent or Metastatic Prostate Cancer (Cohort B)
High Risk Prostate Cancer (Cohort A)

Trial Design

1Treatment groups
Experimental Treatment
Group I: 18F-DCFPyLExperimental Treatment1 Intervention
A bolus of less than or equal to 9 mCi (331 MBq) of IV injection of 18F-DCFPyL
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
18F-DCFPyL Injection
2015
Completed Phase 3
~480

Find a Location

Who is running the clinical trial?

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
563 Previous Clinical Trials
33,286 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,748 Previous Clinical Trials
40,959,363 Total Patients Enrolled
Steven Rowe, M.D., Ph.DPrincipal InvestigatorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
~4 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top